Masayo Tada
Chairman bij SUMITOMO PHARMA CO., LTD.
Profiel
Momenteel is Masayo Tada voorzitter bij Boston Biomedical, Inc. en voorzitter bij Sumitomo Dainippon Pharma Co., Ltd. De heer Tada zit ook in de Raad van Bestuur van Sunovion Pharmaceuticals, Inc. en Sumitovant Biopharma, Inc. Voorheen was de heer Tada President, Chief Executive Officer & Director bij DS Pharma Animal Health Co., Ltd.
Actieve functies van Masayo Tada
Bedrijven | Functie | Begin |
---|---|---|
SUMITOMO PHARMA CO., LTD. | Chairman | 01-04-2018 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Director/Board Member | - |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Chairman | - |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Director/Board Member | - |
Eerdere bekende functies van Masayo Tada
Bedrijven | Functie | Einde |
---|---|---|
ROIVANT SCIENCES LTD. | Director/Board Member | 16-09-2022 |
Sumitomo Pharmaceuticals Co., Ltd. | Director/Board Member | - |
ROIVANT SCIENCES LTD. | Director/Board Member | - |
Sumitomo Pharma Animal Health Co., Ltd.
Sumitomo Pharma Animal Health Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Sumitomo Pharma Animal Health Co., Ltd. is a Japanese company that manufactures and supplies pharmaceuticals, food ingredients, food additives, veterinary medicines, and diagnostics. The private company is based in Osaka, Japan and was founded in 2010. | Chief Executive Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SUMITOMO PHARMA CO., LTD. | Health Technology |
ROIVANT SCIENCES LTD. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Commercial Services |
Sumitomo Pharmaceuticals Co., Ltd. | Health Technology |
Sumitomo Pharma Animal Health Co., Ltd.
Sumitomo Pharma Animal Health Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Sumitomo Pharma Animal Health Co., Ltd. is a Japanese company that manufactures and supplies pharmaceuticals, food ingredients, food additives, veterinary medicines, and diagnostics. The private company is based in Osaka, Japan and was founded in 2010. | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |